查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970985

醫療編碼人工智慧市場－全球產業規模、佔有率、趨勢、機會、預測：按組件、最終用途、地區和競爭對手分類，2021-2031年

AI In Medical Coding Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療編碼人工智慧市場預計將從 2025 年的 24.5 億美元成長到 2031 年的 42.2 億美元，複合年成長率為 9.49%。

在這個領域，包括自然語言處理和機器學習在內的人工智慧技術被用於自動將醫療文件轉換為標準化的字母數字代碼，以用於計費和診斷。推動這一市場成長的關鍵因素包括醫療保健數據的激增以及醫療服務提供者迫切需要最大限度地減少人為錯誤造成的計費錯誤。此外，全球範圍內熟練的醫療編碼員長期短缺，以及透過降低管理成本來簡化收入週期管理的需求，都在加速這些技術的應用。

市場概覽
預測期 2027-2031
市場規模：2025年 24.5億美元
市場規模：2031年 42.2億美元
複合年成長率：2026-2031年 9.49%
成長最快的細分市場 外包
最大的市場 北美洲

根據美國醫學會 (AMA) 的一項調查，到 2025 年，31% 的醫生表示將使用人工智慧 (AI)，尤其是在建立醫療記錄和分配計費代碼方面。儘管 AI 的應用正在不斷成長，但市場在數據準確性和 AI 生成的錯誤所帶來的責任風險方面仍然面臨重大挑戰。演算法可能出現「幻覺」以及對複雜臨床細微差別的誤解，這可能需要持續的人工監督，使實施過程更加複雜，並阻礙醫療機構完全依賴自主編碼解決方案。

市場促進因素

減少理賠拒付和提高支付準確性是推動醫療編碼領域人工智慧應用的當務之急。醫療機構擴大應用機器學習演算法，在提交理賠申請前，根據複雜的支付方規則審核臨床文檔，從而避免因人為疏忽造成的收入損失。隨著監管標準的不斷演變和支付方審核流程的日益嚴格，理賠拒付率不斷上升，因此，這種轉變至關重要，也使得能夠主動識別差異的工具的需求日益成長。 Experian Healthcare 於 2024 年 6 月發布的《2024 年理賠狀況報告》顯示，73% 的醫療服務提供者報告理賠拒付率上升，凸顯了採用自動化解決方案以確保編碼準確性和合規性的緊迫性。

同時，熟練的醫療編碼員長期短缺以及數據量的不斷成長，推動了對營運效率提升的需求。各機構正將大量重複性的醫療記錄處理工作外包給自動化編碼平台，將人力資源集中在複雜病例，並減輕可能導致員工倦怠的行政負擔。這些技術能夠快速處理大量資料集，顯著縮短計費週期，從而變革收入週期管理。例如，Fathom公司在2024年2月發布的新聞稿中宣布，其人工智慧技術在急診醫療案例中實現了90%的自動化率，證明了這些工具在工作量管理方面的有效性。此外，大量資金籌措正用於擴展這些解決方案。 2024年，CodaMetrix公司獲得了4,000萬美元的B輪資金籌措，用於進一步開發其自動化醫療編碼平台。

市場挑戰

數據準確性方面的重大挑戰以及人工智慧生成錯誤可能引發的責任問題，正直接阻礙著全球醫療編碼人工智慧市場的成長。醫療機構對全面採用自主編碼解決方案持謹慎態度，因為演算法的「幻覺」和對複雜臨床細微差別的誤解可能導致嚴重的計費差異和法律後果。這種可靠性的缺失迫使醫療機構持續進行人工監督以檢驗人工智慧的輸出，這與降低管理和營運成本的主要目標相反。因此，人工檢驗的需求降低了投資報酬率，並減緩了人工智慧在醫療系統中的普及速度。

根據醫療集團管理協會 (MGMA) 的數據，到 2025 年，44% 的醫療機構領導者表示，在已實施人工智慧工具的機構中，該技術並未減輕員工的工作量。這項數據凸顯了準確性問題對營運的影響。由於需要持續的人工干預來糾正和檢驗人工智慧產生的數據，機構無法真正享受到自動化所承諾的效率提升。這種未能減輕行政負擔的情況，是人工智慧在醫療編碼領域廣泛應用的主要障礙。

市場趨勢

生成式人工智慧與大規模語言模型（LLM）的融合代表著技術能力的根本性轉變，它超越了基本的關鍵字提取，發展到對非結構化臨床記錄進行深入的脈絡理解。與傳統的基於規則的系統不同，這些先進的模型能夠分析醫生觀察、出院小結和手術報告，自主產生準確的編碼分配，同時也能總結複雜的病歷供檢驗審查。這一趨勢彌合了編碼中的解讀鴻溝，使得對傳統演算法經常錯誤分類的細微臨床數據進行精確處理成為可能。業界對此技術飛躍充滿信心。根據Akasa於2024年10月發布的報告《醫療編碼中生成式人工智慧的潛力－收入週期管理者的視角》，65%的受訪醫療系統收入周期管理者相信，生成式人工智慧將對其醫療編碼業務產生重大影響。

除了其生成能力外，人工智慧在風險調整編碼準確性方面的應用正在重塑基於價值的醫療保健策略，因為它能夠發現那些在人工流程中經常被忽視的慢性疾病。在該模式下，演算法會回顧性和主動性地審核患者記錄，以識別未記錄的層級疾病分類（HCC），從而確保根據患者病情的嚴重程度向健康保險計劃支付適當的報銷。這種應用不同於單純的索賠拒付預防或基於交易的索賠接受，而是側重於收入健康和人群健康數據的長期品質。這一趨勢的具體影響在營運成果中顯而易見。根據 RISE Health 於 2024 年 11 月發表的報導《編碼的十字路口：揭示下一代風險調整人工智慧》，將深度學習人工智慧應用於風險調整審查的健康保險計畫的 ICD 覆蓋率提高了 27%，風險評分準確性和財務績效也得到了直接提升。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：人工智慧在醫療編碼領域的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（內部組件、外包組件）
    • 依最終使用者（醫療服務提供者、醫療計費機構、企業、支付方）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美醫療編碼人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫療編碼人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫療編碼人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲醫療編碼人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲醫療編碼人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球醫療編碼人工智慧市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • 3M Company
  • Nuance Communications, Inc.
  • MedsIT Nexus Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Olive Technologies, Inc.
  • Medicodio Inc.
  • Fathom, Inc.
  • Wolters Kluwer NV
  • Medisys Data Solutions Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27539

The Global AI In Medical Coding Market is projected to expand from USD 2.45 Billion in 2025 to USD 4.22 Billion by 2031, reflecting a compound annual growth rate of 9.49%. This sector involves utilizing artificial intelligence technologies, including natural language processing and machine learning, to automatically convert medical documentation into standardized alphanumeric codes for billing and diagnostic purposes. The primary factors driving this market's growth include the surging volume of healthcare data and the critical need for providers to minimize claim denials resulting from human error. Additionally, the adoption of these technologies is being accelerated by a persistent global shortage of skilled medical coders and the necessity to streamline revenue cycle management by lowering administrative operational costs.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.45 Billion
Market Size 2031USD 4.22 Billion
CAGR 2026-20319.49%
Fastest Growing SegmentOutsourced
Largest MarketNorth America

According to the American Medical Association, 31% of physicians reported in 2025 that they were using AI specifically for documenting medical charts and billing codes. Despite this increasing adoption, the market faces significant obstacles regarding data accuracy and liability risks associated with AI-generated errors. The risk of algorithmic "hallucinations" or the misinterpretation of complex clinical nuances requires continuous human oversight, which can complicate the implementation process and discourage organizations from fully relying on autonomous coding solutions.

Market Driver

The urgent need to mitigate claim denials and improve payment accuracy acts as a primary catalyst for the adoption of AI in medical coding. Healthcare providers are increasingly applying machine learning algorithms to audit clinical documentation against intricate payer rules prior to claim submission, thereby preventing revenue leakage associated with human oversight. This shift is critical as denial rates rise due to evolving regulatory standards and stricter payer adjudication processes, necessitating tools that can preemptively identify discrepancies. In the 'State of Claims 2024' report by Experian Health from June 2024, 73% of healthcare providers indicated that claim denials are increasing, highlighting the urgent need for automated solutions that ensure coding precision and compliance.

Simultaneously, there is an escalating demand for operational efficiency to address the chronic shortage of skilled medical coders and increasing data volumes. Organizations are deploying autonomous coding platforms to handle high-volume, repetitive charts, allowing human staff to focus on complex cases and reducing the administrative burden that leads to workforce burnout. The capability of these technologies to process vast datasets rapidly is transforming revenue cycle management by significantly shortening billing cycles. For example, a February 2024 press release from Fathom noted that their AI technology achieved a 90% automation rate for emergency medicine encounters, demonstrating the capacity of these tools to manage workload volume. Furthermore, the financial commitment to scaling these solutions is evident; CodaMetrix secured $40 million in Series B funding in 2024 to further develop its autonomous medical coding platform.

Market Challenge

The significant challenge of data accuracy and the potential for liability arising from AI-generated errors is directly hampering the growth of the Global AI In Medical Coding Market. Healthcare organizations are hesitant to fully integrate autonomous coding solutions because algorithmic hallucinations or the misinterpretation of complex clinical nuances can lead to severe billing discrepancies and legal repercussions. This lack of reliability forces providers to maintain continuous human oversight to validate AI outputs, which counteracts the primary objective of reducing administrative operational costs. Consequently, the necessity for manual verification diminishes the return on investment and slows the speed of implementation across health systems.

According to the Medical Group Management Association, 44% of medical practice leaders using AI tools reported in 2025 that the technology had not reduced their staff workload. This statistic underscores the operational impact of the accuracy challenge, as the persistent need for human intervention to correct or verify AI-generated data prevents organizations from realizing the efficiency gains promised by automation. This failure to alleviate the administrative burden creates a significant barrier to the widespread adoption of AI in the medical coding sector.

Market Trends

The Integration of Generative AI and Large Language Models (LLMs) represents a fundamental shift in technical capability, moving beyond basic keyword extraction to the deep contextual understanding of unstructured clinical narratives. Unlike earlier rule-based systems, these advanced models analyze physician notes, discharge summaries, and operative reports to autonomously generate accurate code assignments while simultaneously summarizing complex medical histories for validator review. This trend addresses the interpretative gap in coding, allowing for the precise handling of nuanced clinical data that traditional algorithms often misclassify. The industry confidence in this technological leap is substantial; according to the 'Revenue cycle leaders see gen AI's medical coding potential' report by Akasa in October 2024, 65% of surveyed health system revenue cycle leaders believe that generative AI will have a substantial effect on their medical coding operations.

Concurrent with generative capabilities, the Utilization of AI for Risk Adjustment Coding Accuracy is reshaping value-based care strategies by uncovering chronic conditions that manual processes frequently overlook. In this model, algorithms retrospectively and prospectively audit patient charts to identify undocumented Hierarchical Condition Categories (HCCs), ensuring that health plans receive appropriate reimbursement commensurate with patient acuity. This application is distinct from simple denial prevention as it focuses on revenue integrity and long-term population health data quality rather than transactional claim acceptance. The tangible impact of this trend is evident in operational outcomes; according to the 'Coding at a crossroads: Unpacking the next generation of AI for risk adjustment' article by RISE Health in November 2024, a health plan implementing deep learning AI for risk adjustment reviews achieved a 27% increase in ICD capture, directly improving their risk score accuracy and financial performance.

Key Market Players

  • 3M Company
  • Nuance Communications, Inc.
  • MedsIT Nexus Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Olive Technologies, Inc.
  • Medicodio Inc.
  • Fathom, Inc.
  • Wolters Kluwer N.V.
  • Medisys Data Solutions Inc.

Report Scope

In this report, the Global AI In Medical Coding Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI In Medical Coding Market, By Component

  • In-House
  • Outsourced

AI In Medical Coding Market, By End Use

  • Healthcare Providers
  • Medical Billing
  • Companies
  • Payers

AI In Medical Coding Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI In Medical Coding Market.

Available Customizations:

Global AI In Medical Coding Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI In Medical Coding Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (In-House, Outsourced)
    • 5.2.2. By End Use (Healthcare Providers, Medical Billing, Companies, Payers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America AI In Medical Coding Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States AI In Medical Coding Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada AI In Medical Coding Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico AI In Medical Coding Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By End Use

7. Europe AI In Medical Coding Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany AI In Medical Coding Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By End Use
    • 7.3.2. France AI In Medical Coding Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom AI In Medical Coding Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy AI In Medical Coding Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain AI In Medical Coding Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By End Use

8. Asia Pacific AI In Medical Coding Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China AI In Medical Coding Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By End Use
    • 8.3.2. India AI In Medical Coding Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan AI In Medical Coding Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea AI In Medical Coding Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia AI In Medical Coding Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By End Use

9. Middle East & Africa AI In Medical Coding Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia AI In Medical Coding Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE AI In Medical Coding Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa AI In Medical Coding Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By End Use

10. South America AI In Medical Coding Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil AI In Medical Coding Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia AI In Medical Coding Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina AI In Medical Coding Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global AI In Medical Coding Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. 3M Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Nuance Communications, Inc.
  • 15.3. MedsIT Nexus Inc.
  • 15.4. Optum, Inc.
  • 15.5. Oracle Corporation
  • 15.6. Olive Technologies, Inc.
  • 15.7. Medicodio Inc.
  • 15.8. Fathom, Inc.
  • 15.9. Wolters Kluwer N.V.
  • 15.10. Medisys Data Solutions Inc.

16. Strategic Recommendations

17. About Us & Disclaimer